MannKind CorporationNASDAQ: MNKD

MannKind to Participate in Upcoming Investor Conferences

· Issued by MannKind Corporation via GlobeNewswire

Summary by 6ix AI

MannKind Corporation, a biopharmaceutical company, said CEO Michael Castagna and CFO Chris Prentiss will give a business update at two investor conferences in London on November 17 and November 18, 2026.

Key details

  • UBS Global Biopharma Conference: fireside chat on Tuesday, November 17, 2026, at 11:20-11:50 a.m. GMT.
  • Jefferies Global Healthcare Conference: presentation on Wednesday, November 18, 2026, at 8:00-8:25 p.m. GMT.
  • Live webcasts will be on the Events & Presentations section of MannKind's Investor Relations website, with replays available for approximately 90 days after the conference.

6ix AI wrote this summary from the release below and checked it against the release.

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), today announced that Chief Executive Officer, Michael Castagna, and Chief Financial Officer, Chris Prentiss, will provide a business update at two upcoming investor conferences in London.

UBS Global Biopharma Conference
Fireside Chat, Tuesday, November 17 at 11:20-11:50 a.m. GMT

Jefferies Global Healthcare Conference
Presentation, Wednesday, November 18 at 8:00-8:25 p.m. GMT

A live webcast of the presentations will be available on the Events & Presentations section of MannKind’s Investor Relations website. A replay of the webcast will be available on the website for approximately 90 days following the conference.

About MannKind
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.

Learn more at mannkindcorp.com.

View original source (GlobeNewswire)MannKind Corporation on 6ix

Story so far

Earlier from MannKind

All MannKind news releases